Listen to ASX-listed Cynata Therapeutics Managing Director Ross Macdonald talk to Matt Birney on the Bulls N’ Bears Report about Cynata’s upcoming clinical trial of its remarkable stem cell related therapies that has been green-lighted by the American FDA.
